Boehringer Ingelheim announces acquisition of T3 Pharmaceuticals
Boehringer Ingelheim has announced the acquisition of Switzerland-based biotech company T3 Pharmaceuticals in a deal valued at up to CHF450m ($509m).
Ingelheim Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ingelheim Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ingelheim Board Today - Breaking & Trending Today
Boehringer Ingelheim opens new biotechnology R&D centre in Germany
Boehringer Ingelheim has opened its new €350m advanced Biologicals Development Center (BDC) in Biberach an der Riß, Germany.